GeneDrive COVID19 Testkits
DIVOC has partnered with GeneDrive to bring their Genedrive® 96 SARS-CoV-2 Kit to the Indian market.
This kit has unique propositions that make it suitable for the Indian environment. It has been approved by ICMR with sensitivity rates and specificity rates of 100.
This kit has unique propositions that make it suitable for the Indian environment. It has been approved by ICMR with sensitivity rates and specificity rates of 100.
Reliable ResultsThe Genedrive® 96 SARS-CoV-2 Kit is a novel Polymerase Chain Reaction (PCR) assay designed to detect active infection in COVID-19 patients. During CE-IVD evaluations on 180 randomised specimens, the Genedrive® 96 SARS-CoV-2 Kit achieved 100% sensitivity and 98.2% specificity, placing it in a top tier performance table for COVID-19 PCR tests.
|
Simpler Workflow Genedrive’s PCR bead format eliminates the need for the time consuming and error prone reagent preparation required in all other open-platform test kits. The proprietary format streamlines laboratory workflow, allowing more tests to be performed in a day. Patient samples are simply mixed with the PCR beads, and are then analysed on a variety of existing third-party real time PCR platforms.
|
Temperature StableThe Genedrive® 96 SARS-CoV-2 kit is stable at ambient temperatures which eliminates the need for cold
storage, making the test very practical for Indian markets. Given its ease of use and temperature stability, the kit can be employed in remote and rural areas. |